Hypoxia is the depletion of oxygen in the blood and is present under several physiological and pathological conditions, including lung disease, heart attack and high altitude exposure. Adaption to hypoxia is mediated by hypoxia-induced factors (HIFs). Find resources for hypoxia research, including tools for HIF and prolyl hydroxylase detection.
Hypoxia
- YC-1, Activator of Guanylyl cyclase; α 1β 1;Activator of Guanylyl cyclase; α 2β 1
Cas#:170632-47-0
Starting at $75.90
- Topotecan hydrochloride, DNA topoisomerase I, mitochondrial inhibitor
Cas#:119413-54-6
Starting at $134.90
- 2-(3-Trifluoromethylanilino)benzoic Acid, Channel blocker of CaCC;Inhibitor of Cx23;Inhibitor of Cx25;Inhibitor of Cx26;Inhibitor of Cx30;Inhibitor of Cx30.2;Inhibitor of Cx30.3;Inhibitor of Cx31;Inhibitor of Cx31.1;Inhibitor of Cx31.9;Inhibitor of Cx32;Inhibitor of Cx36;Inhibitor of Cx37;Inhibit
Cas#:530-78-9
Starting at $23.90
- ZM 241385, Antagonist of A 1 receptor;Antagonist of A 2A receptor;Antagonist of A 2B receptor;Antagonist of A 3 receptor
Cas#:139180-30-6
Starting at $107.90